Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Tel: +44 (0)1273 434 943
Email: [email protected]
A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives but only 7% of those with targetable mutations were able to access the appropriate adult drug. The pilot including more than 200 children found that half had gene mutations that are targetable by adult cancer drugs that are either available as standard treatment or via clinical trials – signalling a new era of precision medicine for young patients. Although few children on the study went on to receive adult drugs, those who did receive targeted therapies
---------------------------
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.